ADMA Biologics, Inc. vs. Halozyme Therapeutics, Inc.
ADMA Biologics, Inc. and Halozyme Therapeutics, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ADMA | HALO | |
|---|---|---|
| Market Cap | $2.93 billion | $13.96 billion |
HALO leads on 1 of 1 size & scale factors.
Risk & Sentiment
| ADMA | HALO | |
|---|---|---|
| Short Interest | 0.09% | 9.79% |
ADMA leads on 1 of 1 risk & sentiment factors.
Dig deeper: ADMA overview, ADMA financials, HALO overview, HALO financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.